TP53 and pancreatic neoplasm: The potential treatment of echinomycin to induce autophagic cell death can likely be used beyond pancreatic cancer, as echinomycin has demonstrated protection against relapse of acute myeloid leukemia [56] and in murine models of aggressive TP53-mutated Acute Myeloid Leukemia (AML) [57].